Sen. Xochitl Gálvez, the Mexican opposition nominee for president, chose to visit a suburb north of Houston for her first campaign event abroad. Research scholar Rodrigo Montes de Oca explains why it was a smart choice — and what the visit shows about the dark horse candidate.
Federal marijuana legalization is on the horizon — and it’s time for the DEA to get behind the policy changes and move on to fighting more dangerous drugs, writes nonresident fellow Gary Hale.
The creation of a new industry of brain capital technologies could stimulate major economic activity, create jobs, and contribute to technological advances for the U.S. and its allies, write Harris Eyre, Rachel Meidl and co-authors.
This paper builds on social network analysis (SNA) and the use of node similarity-based algorithms to make link predictions about Mexico’s network of criminal organizations.
Oscar Contreras Velasco, Nathan P. Jones, Daniel Weisz Argomedo, John P. Sullivan, Chris CallaghanAugust 30, 2023
What are the ethical and policy implications of embryoids — cell-based embryo models that mimic the early stages of human development — for use in research? Center for Health and Biosciences experts Ana Iltis and Kirstin R.W. Matthews summarize the concerns and questions raised in the recent literature.
Kirstin R.W. Matthews, Ana S. IltisAugust 21, 2023
This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick LoveAugust 10, 2023
Among his 2024 Democratic challengers, Biden has the clearest foreign policy record — but it may be difficult to maintain his current balancing act on Ukraine and China when it comes to the general election, writes Bonner Means Baker Fellow Joe Barnes.